U.S. Markets close in 1 hr 47 mins

iCAD, Inc. (ICAD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.95+0.01 (+0.25%)
As of 2:09PM EDT. Market open.
People also watch
IRIXICCCINODIDSYDRAD

iCAD, Inc.

98 Spit Brook Road
Suite 100
Nashua, NH 03062
United States
603-882-5200
http://www.icadmed.com

SectorTechnology
IndustryTechnical & System Software
Full Time Employees116

Key Executives

NameTitlePayExercisedAge
Mr. Kenneth M. FerryChief Exec. Officer and Director744.31kN/A63
Mr. Richard C. ChristopherChief Financial Officer, Exec. VP, Treasurer and Sec.25.58kN/A47
Ms. Stacey M. StevensChief Strategy, Exec. VP of Marketing & Strategy and Commercial Officer413.83kN/A49
Mr. R. Scott AregladoVP and Corp. Controller236.9kN/AN/A
Ms. Annette L. HerouxVP of Admin.N/AN/A60
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include PowerLook Mammo Detection, which detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer’s network that receives patient studies from the imaging modality, performs CAD and density assessment analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the company’s digital mammography CAD products comprise magnetic resonance imaging products to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. iCAD, Inc. has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.

Corporate Governance

iCAD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.